MTOR and glioma: As illustrated in Fig. 2E, compared with m7Gcluster-B, m7Gcluster-A presented a significant survival advantage with inositol phosphate metabolism, phosphatidylinositol, glioma, neurotrophin, ErbB, mTOR, insulin, Wnt signaling pathways as well as other enrichment pathways.